NCT03748186 2025-08-20Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersSutro Biopharma, Inc.Phase 1 Completed136 enrolled